Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Catalyst Pharmaceutical Partners, Inc. (CPRX)  
$15.62 0.14 (0.89%) as of 4:30 Fri 6/7


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 103,650,000
Market Cap: 1.62(B)
Last Volume: 789,519 Avg Vol: 1,671,490
52 Week Range: $11.62 - $17.29
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drugs - Generic

Member Indexes:
    NASDAQ COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  604
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Catalyst Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing medicines for patients living with rare diseases. Co.'s primary product, Firdapse®, is used for the treatment of adult patients (ages 17 and above) with Lambert-Eaton, Myasthenic Syndrome, a rare autoimmune neuromuscular disorder characterized by muscle weakness of the limbs. Co. has developed its vigabatrin (CPP-109) as a generic version of Sabril®. Co. has an agreement with Endo International plc's subsidiary, Endo Ventures Limited, for the development and commercialization of generic Sabril® tablets through Endo's U.S. Generic Pharmaceuticals segment, Par Pharmaceutical.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 152,656 276,656 406,656 4,306,172
Total Sell Value $2,459,484 $4,152,934 $5,994,534 $64,305,632
Total People Sold 5 6 7 13
Total Sell Transactions 5 8 11 55
End Date 2024-03-12 2023-12-10 2023-06-11 2022-06-11

   
Records found: 439
  Page 14 of 18  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Mcenany Patrick J President and CEO   •       •      –    2012-12-17 4 B $0.45 $44,500 D/D 100,000 3,449,997 2.81     -
   Biomarin Pharmaceutical Inc 10% Owner   –       –       •   2012-12-08 4 B $0.75 $3,750,000 D/D 5,000,000 6,666,667 2.45     -
   Coelho Philip H Director   –       •      –    2012-11-15 4 B $0.41 $9,857 I/I 24,000 24,000 2.1     -
   O'keeffe Charles B Director   –       •      –    2012-11-15 4 B $0.42 $10,475 D/D 25,000 157,126 2.39     -
   Mcenany Patrick J President and CEO   •       •       •   2012-11-15 4 B $0.42 $42,010 D/D 100,000 3,349,997 3.23     -
   Miller Steve Chief Operating Officer   •       –      –    2012-07-03 4 B $0.55 $21,951 D/D 40,000 114,754 2.74     -
   Grande Alicia VP, Treasurer and CFO   •       –      –    2012-07-03 4 B $0.54 $10,980 D/D 20,000 66,346 2.74     -
   Mcenany Patrick J President and CEO   •       •       •   2012-07-03 4 B $0.54 $375 D/D 700 3,249,997 3.15     -
   Mcenany Patrick J President and CEO   •       •       •   2012-07-02 4 B $0.54 $16,418 D/D 30,500 3,249,297 3.15     -
   Mcenany Patrick J President and CEO   •       •       •   2012-05-30 4 B $0.58 $5,790 D/D 10,000 3,218,797 3.15     -
   Grande Alicia VP, Treasurer and CFO   •       –      –    2012-05-30 4 B $0.57 $9,861 D/D 17,300 46,346 2.74     -
   Wallace Milton J Director   –       •      –    2012-05-29 4 B $0.57 $6,327 D/D 11,100 539,184 2.39     -
   Tierney David S Director   –       •      –    2012-05-29 4 B $0.58 $11,696 D/D 20,000 205,401 2.39     -
   Wallace Milton J Director   –       •      –    2012-05-24 4 B $0.80 $100,000 D/D 125,000 528,084 2.39     -
   Winship M Douglas VP, Regulatory Operations   •       –      –    2012-05-24 4 B $0.80 $10,000 D/D 12,500 17,294 2.74     -
   O'keeffe Charles B Director   –       •      –    2012-05-24 4 B $0.80 $25,000 D/D 31,250 112,126 2.39     -
   Huckel Hubert E Md Director   –       •      –    2012-05-24 4 B $0.80 $100,000 I/I 125,000 1,304,134 2.1     -
   Mcenany Patrick J President and CEO   •       •       •   2012-05-24 4 B $0.80 $25,000 D/D 31,250 3,208,797 3.23     -
   Mcenany Patrick J President and CEO   •       •       •   2011-12-14 4 B $1.06 $10,598 D/D 10,000 3,177,547 3.15     -
   Coelho Philip H Director   –       •      –    2011-09-06 4 S $1.25 $270,683 D/D (216,546) 87,636     -
   Weinstein Jack V.P., Treasurer & CFO   •       –      –    2010-12-20 4 B $0.95 $2,378 D/D 2,500 14,493 2.66     -
   Mcenany Patrick J President and CEO   •       •       •   2010-07-07 4 B $0.90 $5,342 D/D 5,751 3,131,381 3.15     -
   Mcenany Patrick J President and CEO   •       •       •   2010-07-06 4 B $0.92 $184 D/D 200 3,125,630 3.15     -
   O'keeffe Charles B Director   –       •      –    2010-06-17 4 B $1.05 $2,099 D/D 2,000 80,876 2.31     -
   Coelho Philip H Director   –       •      –    2010-06-16 4 B $1.04 $5,200 D/D 5,000 304,182 2.39     -
  439 Records found
  Previous  10  11  12  13  14  15  16  17  18   
  Page 14 of 18
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us